Comparison Overview

Mahakam Beta Farma

VS

SGS Pharma

Mahakam Beta Farma

Jalan Pulo Kambing Raya No 9 Rawa Terate, Jakarta 13920, ID
Last Update: 2025-03-15 (UTC)
Between 750 and 799

We are an innovative, competitive and leading pharmaceutical and healthcare company with strong brands and sustainable double digits growth. We are proud to deliver high quality products and excellent services to our customers so they can have better lives.

NAICS: 325
NAICS Definition:
Employees: 1,001-5,000
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

SGS Pharma

None
Last Update: 2025-03-15 (UTC)
Between 750 and 799

Optimize your medicines and medical device development to get to the market safely and quickly, utilizing SGS Pharma's unique expertise, resources, and network. Contact us: [email protected] ---- We are SGS ‚Äì the world's leading testing, inspection, and certification company. We are recognized as the global benchmark for sustainability, quality, and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories. --- Intellectual Property Statement: Except where expressly stated otherwise, all intellectual property rights, including copyright and trademarks, in any and all communications and materials in any form published by or on behalf of SGS are owned by SGS Soci√©t√© G√©n√©rale de Surveillance SA, Switzerland. Link to statement on sgs.com: https://www.sgs.com/en/intellectual-property-statement

NAICS: 325
NAICS Definition:
Employees: 10,001+
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/mahakam-beta-farma.jpeg
Mahakam Beta Farma
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/sgs-life-sciences.jpeg
SGS Pharma
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Mahakam Beta Farma
100%
Compliance Rate
0/4 Standards Verified
SGS Pharma
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Mahakam Beta Farma in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for SGS Pharma in 2025.

Incident History — Mahakam Beta Farma (X = Date, Y = Severity)

Mahakam Beta Farma cyber incidents detection timeline including parent company and subsidiaries

Incident History — SGS Pharma (X = Date, Y = Severity)

SGS Pharma cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/mahakam-beta-farma.jpeg
Mahakam Beta Farma
Incidents

No Incident

https://images.rankiteo.com/companyimages/sgs-life-sciences.jpeg
SGS Pharma
Incidents

No Incident

FAQ

SGS Pharma company demonstrates a stronger AI Cybersecurity Score compared to Mahakam Beta Farma company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, SGS Pharma company has disclosed a higher number of cyber incidents compared to Mahakam Beta Farma company.

In the current year, SGS Pharma company and Mahakam Beta Farma company have not reported any cyber incidents.

Neither SGS Pharma company nor Mahakam Beta Farma company has reported experiencing a ransomware attack publicly.

Neither SGS Pharma company nor Mahakam Beta Farma company has reported experiencing a data breach publicly.

Neither SGS Pharma company nor Mahakam Beta Farma company has reported experiencing targeted cyberattacks publicly.

Neither Mahakam Beta Farma company nor SGS Pharma company has reported experiencing or disclosing vulnerabilities publicly.

Neither Mahakam Beta Farma nor SGS Pharma holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Mahakam Beta Farma company nor SGS Pharma company has publicly disclosed detailed information about the number of their subsidiaries.

Neither Mahakam Beta Farma company nor SGS Pharma company has publicly disclosed the exact number of their employees.

Neither Mahakam Beta Farma nor SGS Pharma holds SOC 2 Type 1 certification.

Neither Mahakam Beta Farma nor SGS Pharma holds SOC 2 Type 2 certification.

Neither Mahakam Beta Farma nor SGS Pharma holds ISO 27001 certification.

Neither Mahakam Beta Farma nor SGS Pharma holds PCI DSS certification.

Neither Mahakam Beta Farma nor SGS Pharma holds HIPAA certification.

Neither Mahakam Beta Farma nor SGS Pharma holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X